11836805

Source:http://linkedlifedata.com/resource/pubmed/id/11836805

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007559, umls-concept:C0010674, umls-concept:C0030705, umls-concept:C0444889, umls-concept:C0591535, umls-concept:C1442770, umls-concept:C1521827, umls-concept:C1621583, umls-concept:C1707883
pubmed:issue	3
pubmed:dateCreated	2002-2-11
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/11836805-12422350
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8510590
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Ceftazidime
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	8755-6863
pubmed:author	pubmed-author:BellonGabrielG, pubmed-author:ChablozClaireC, pubmed-author:PlasseJean-ClaudeJC, pubmed-author:TerrierAnnickA
pubmed:issnType	Print
pubmed:volume	33
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	232-3
pubmed:dateRevised	2006-3-28
pubmed:meshHeading	pubmed-meshheading:11836805-Ceftazidime, pubmed-meshheading:11836805-Cystic Fibrosis, pubmed-meshheading:11836805-Drug Administration Schedule, pubmed-meshheading:11836805-Humans, pubmed-meshheading:11836805-Infusions, Intravenous, pubmed-meshheading:11836805-Kidney, pubmed-meshheading:11836805-Liver, pubmed-meshheading:11836805-Pseudomonas Infections, pubmed-meshheading:11836805-Retrospective Studies, pubmed-meshheading:11836805-Treatment Outcome
pubmed:year	2002
pubmed:articleTitle	To the editor: Is it safe to administer a continuous infusion of ceftazidime (Fortum) prepared for 24 hours in cystic fibrosis (CF) patients?
pubmed:publicationType	Letter